SIGY
Sigyn Therapeutics, Inc.
Key Financials
Revenue
$143322
↑ 405.6%
Net Income
$-3340212
↑ 19.4%
Operating Income
$-2519242
↓ 2.6%
Total Liabilities
$4.7M
↑ 25.1%
Gross Profit
$107657
↑ 477.7%
EPS (Diluted)
$-2.51
↑ 33.4%
Total Assets
$213719.00
↓ 33.6%
Shareholders' Equity
$-4457624.00
↓ 30.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-K | 3/31/2026 | View on SEC |
| 8-K | 2/20/2026 | View on SEC |
| SCHEDULE 13G/A | 1/14/2026 | View on SEC |
| 10-Q | 11/14/2025 | View on SEC |
| 10-Q | 9/5/2025 | View on SEC |
| 8-K | 8/15/2025 | View on SEC |
| NT 10-Q | 8/15/2025 | View on SEC |
| 10-Q | 5/20/2025 | View on SEC |
| NT 10-Q | 5/15/2025 | View on SEC |
| 10-K | 4/15/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SIGY |
| Company Name | Sigyn Therapeutics, Inc. |
| CIK | 1642159 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 619-368-2000 |